Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevirapine QD vs BID vs Atazanavir/r in Naive HIV-1
NCT00389207Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2006
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of nevirapine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Boehringer Ingelheim. Started Oct 2006; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00389207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389207.